H34.8132 Central retinal vein occlusion, bilateral, stable

Name of the Condition

• Central Retinal Vein Occlusion, Bilateral, Stable (ICD-10: H34.8132)

Summary

Central retinal vein occlusion (CRVO) occurs when the main vein draining blood from the retina becomes blocked, disrupting blood flow and potentially leading to vision problems or loss. In this case, both eyes are affected, and the condition is stable, meaning there is no active progression or acute complications such as macular edema or neovascularization. The condition typically impacts both eyes and may result in symptoms ranging from mild blurring to severe vision loss, depending on the severity of the occlusion.

Causes

CRVO is often caused by a blood clot in the central retinal vein. Underlying factors such as atherosclerosis, inflammation, or compression of the vein may contribute to the blockage. Systemic conditions like hypertension or hypercoagulability can also play a role in the development of the occlusion.

Risk Factors

• Advanced age
• High blood pressure
• Diabetes mellitus
• Glaucoma
• High cholesterol
• Smoking
• Cardiovascular disease
• Blood disorders (e.g., hypercoagulability)

Symptoms

• Sudden, painless vision loss in both eyes
• Blurred or distorted vision
• Floaters or dark spots in the visual field
• Peripheral vision loss

Diagnosis

Diagnosis involves a comprehensive eye examination, including visual acuity testing, dilated funduscopy, and imaging studies such as fluorescein angiography or optical coherence tomography (OCT) to assess retinal structure and blood flow. The stability of the condition is determined by the absence of active complications like macular edema or neovascularization.

Treatment Options

Treatment focuses on managing underlying risk factors, such as controlling blood pressure or diabetes, and monitoring for complications. In stable cases, observation may be sufficient, but interventions like anti-VEGF therapy or laser photocoagulation may be considered if complications arise.

Prognosis and Follow-Up

The prognosis for stable bilateral CRVO depends on the extent of retinal damage and the presence of residual vision. Regular follow-up with an ophthalmologist is essential to monitor for any progression or development of complications, such as macular edema or neovascularization.

Complications

While the condition is stable, complications can still occur, including macular edema, retinal neovascularization, or glaucoma. These may require additional treatment to prevent further vision loss.

Lifestyle & Prevention

Managing systemic conditions like hypertension and diabetes, quitting smoking, and maintaining a healthy diet can help reduce the risk of CRVO. Regular eye examinations are recommended for early detection and management.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision changes, such as blurring, floaters, or vision loss, as these may indicate a progression of the condition or a new complication.

Tips for Medical Coders

Document the bilateral nature of the occlusion and confirm the absence of active complications (e.g., macular edema, neovascularization) to support the "stable" designation. Ensure clinical notes specify the condition's stability to justify the use of this code.